Speed Biosystems, LLC
Rockville, MD
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Sole Proprietorship
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 10120 Limestone Ct, Rockville, MD 20854, USA
- Website
- speedbiosystems.com
- Founded
- 2011
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $395,790 |
| FY2024 | $641,835 |
| FY2023 | $625,860 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Speed Biosystems, LLC is a minority-owned, small disadvantaged business located in Rockville, Maryland, registered in the System for Award Management (SAM.gov) since October 2011. The company specializes in producing proprietary biological research products, with a primary focus on TURBO293 Transfection Reagents, which are critical components for advanced scientific research, particularly in coronavirus and vaccine development. As a limited liability company structured as a sole proprietorship, Speed Biosystems has established itself as a unique provider of specialized reagents for molecular and cellular research, particularly within the biotechnology and immunological research domains.
The company has consistently secured federal contract awards from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), primarily through sole-source purchase orders. These contracts, ranging from $63,950 to $249,000, have been exclusively focused on providing TURBO293 Transfection Reagents for COVID-19 related research, vaccine production, and immunogen development. The contracts have supported critical scientific work at NIH's Vaccine Research Center in Bethesda, Maryland, with deliveries typically involving 45-78 units of their specialized transfection reagents. While none of the contracts utilized small business set-aside designations, Speed Biosystems has demonstrated its unique market position by being the sole owner, developer, and seller of these proprietary reagents. Since 2019, the company has accumulated over $3 million in federal contracts, primarily from NIAID and the National Cancer Institute, underscoring its significant role in supporting advanced biomedical research infrastructure.
Quick answers
Is Speed Biosystems, LLC registered in SAM.gov?
Yes. Speed Biosystems, LLC's SAM.gov registration is active through September 9, 2027.
What is Speed Biosystems, LLC's CAGE code?
Speed Biosystems, LLC's CAGE code is 6KCG3, and its Unique Entity ID (UEI) is NEBAJX4Q5NJ5.
How much has Speed Biosystems, LLC received in federal contracts?
Federal contracts obligated $395,790 to Speed Biosystems, LLC in fiscal year 2025 and $1,663,485 in fiscal years 2023 through 2027.
How does Speed Biosystems, LLC rank among federal contractors?
Speed Biosystems, LLC ranked #50 in NAICS 325414 and #58 in NAICS 325413 in FY2025.
What is Speed Biosystems, LLC's most recent federal award?
Speed Biosystems, LLC's most recent federal contract award is TURBO293 transfection reagent for HEK293 cells QTY 78 (ambis #2269961) (75N93025P01091), from National Institute of Allergy and Infectious Diseases (NIH), on September 26, 2025.
On GovTribe
See Speed Biosystems, LLC's full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors